DR ADRIANA LE ALLERGY I IMMUNOLOGY
DR ADRIANA LE ALLERGY I IMMUNOLOGY
Dr Adriana Le MBBS FRACP
Clinical Immunologist /Allergist
EFTA00263307
W allergyimmune.com.au
Your Appointment
0014)) yeasia ViCOMII C"
ID Summit Health Centre, Mt Barker eta,
ID Clare Medical Centre, Claren 3,7rnik
0 Health on Washington, Angaston
I
EFTA00263308
0 Pe Government of South Australia e
Liyt"' SA Health d. t
Wa°aro° Hospital
York* and Northern Local
Health Network
Ernest Terrace
WALLAROO SA 5556
PMB 1
WALLAR00 SA 5556 \tor---W Go-ceteneci
cfeOcitrri Infepticn I -lks----ocicticar.
Po bal< K cid t. sfl 01354-Patient presented to Wallaroo Emergency bepartment Please find a copy enclosed for your records
Administration
Wallaroo Hospital
EFTA00263309
Dr Richard Daehn
FRACGP, B.Med.S
Provider Number:
Email:
Argus:
Healthlink: kadmedas
Dr Adriana Le
85 Wellington Road
MOUNT BARKER 5251
Ph: (08) 8406 7736
Fax: (08) 8004 9151
Dear Dr Adriana,
Re: Miss
DOB:
Address:
Thank you for seeing Miss
Presenting Problem age 50 yrs. Kadina Medical Associates
PO Box 371
Unit 77-79 Port Road
Kadina SA 5554
Phone (Home):
Phone (Work):
Phone (Mobile): 16 December 2021
In Association With:
Dr Graham Morris, Dr Michael Gregg , Dr Fail Junejo, Dr Hannah Wellington, Dr Will Dachn
EFTA00263310
Abdominoplasty
Allergies
Penicillins
Lexapro
Champix
olanzapine
Family History
father high chol borderline diabetes
Current Medications
Nicotine 21 mg per 24hour Transdermal Drug APPLY I NEW PATCH EVERY 24 IIRS TO
Delivery System (Transdermal patch) NONHAIRY, CLEAN, DRY SKIN ON
2lmg/24hour(Step 52.5 mg/patch) [28] TRUNK, UPPER ARM; HOLD IN PLACE
FOR 10-20 SEC WITH PALM OF HAND;
ROTATE APPLIC SITE (DO NOT
REAPPLY TO SAME SITE WITHIN
SEVERAL DAYS).
!RN Medications
Hiprex Tablets lg [100]
Short Term Medications 1 tab twice daily
Should any of the above need clarification, please feel free to contact me by phone on 8821 3133, or e-mail me at
Can you please inform me if this patient does not make an appointment or does not keep an
appointment.
Yours sincerely,
Dr Richard Daehn
EFTA00263311
04/02/2022 13:26 (FAX) P.001/001
0 DR ADRIAN A LE ALLERVY I IMMLN0LUCtr
CONTACT
W ailergyln,mune.com.au
04/02/2022
Or Rithawd 0aehn
Wins Mediad Asunlekst
PO Box 371
KADINA SA 5.554
Dear Richard. ImmunologistAilergist
MBBS FRACP
Practices
Summit Health Centre
85 Wel:r.gton Rd, Mt Barker 4215360F
dare Medical Centre
41 Oid N Rd, Clare
421536ET
Health on Washington
3-7 Fife St, Angastcn
421538GL
Kind Regagis,
Di Addend Le
EFTA00263312
This vaccine is subject to additional monitoring. This will allow quick identification of new safety information. You can
help by reporting any side effects you may get. You can report side effects to your doctor, or directly at
wtvw.tga.gov.au/reporting-problems.
MO° Active Ingredient: DIT162b2 NRNAI COMIRNATY' COVID-19 VACCINE
This vaccine has provisional approval in Australia to prevent COVID-19 disease caused by SARS.CoV-.2 virus In adults and
adolescents from 16 years of age and older. This approval has been granted on the basis of short term safety and efficacy data.
Evidence of longer term efficacy and safety from ongoing clinical trials and vaccination in the community continues to be
gathered and assessed.
Consumer Medicine Information (CMI)
This leaflet provides important information about using
COMIRNATY. You should also speak to your doctor or
pharmacist if you would like further information or if you
have any concerns or questions about receiving
COMIRNATY.
Where to find information in this leaflet
• Why am I being given COMIRNATY?
• What should I know before I am given COIVIIRNATY?
3. What i(1 am taking other medicines?
4. How will I be given COMIRNATY?
s. what should I know while beinggiven COMIRNATY?
6. Are there any side effects?
7. Product details
1. Why am I being given COMIRNATY?
COMIRNATY contains the active ingredient BNT162b2
(mRNA]. COMIRNATY is an mRNA (messenger ribonucleic
acid) vaccine.
COMIRNATY Is a vaccine given to prevent COVID-19
disease caused by SARS-CoV-2 virus in adults and
adolescents from 16 years of age and older.
COMIRNATY works by triggering your immune system to
produce antibodies and blood cells that work against the
virus, to protect against COVID-19 disease.
2. What should I know before I am given
COMIRNATY?
Warnings
COMIRNATY should not be given:
1. if you are allergic to BNT162b2 [mRNA( or any of the
ingredients listed at the end of this leaflet.
Check with your doctor if you have:
• had a severe allergic reaction or breathingproblems
after any other vaccine or after being given
COMIRNATY in the past.
• fainted following any needle injection. • a severe illness or infection with high fever. However,
you can have your vaccination if you have a mild fever
or upper airway infection like a cold.
• a weakened immune system, such as due to HIV
infection or are on a medicine that affects your
immune system.
• a bleeding disorder, bruise easily or are on a blood
thinning medicine.
As with any vaccine, COMIRNATY may not fully protect all
those who receive it and it is not known how long you will
be protected.
During treatment, you may be at risk of developing certain
side effects. It is important you understand these risks and
how to monitor for them. See additional information
under Section 6. Are there any side effects?
Pregnancy and breastfeeding
If you are pregnant or breast-feeding, think you may be
pregnant or are planning to have a baby, ask your doctor
or pharmacist for advice before you receive this vaccine.
Children and adolescents
COMIRNATY should not be given to children under 16
years.
3. What if I am taking other medicines?
Tell your doctor or pharmacist if you are taking, have
recently taken or might take any other medicines,
including any medicines, vitamins or supplements that you
buy without a prescription from your pharmacy,
supermarket or health food shop.
Tell your doctor or pharmacist if you have recently
received any other vaccine.
Check with your doctor or pharmacist if you are not sure
about what medicines, vitamins or supplements you are
taking and if these affect, or are affected by,
COMIRNATY.
4. How will I be given COMIRNATY?
• COMIRNATY will be given as an injection into the
muscle of your upper arm by a doctor, nurse or
pharmacist.
COMIRNATrY
EFTA00263313
• You will be given one dose followed by a second dose
at least 21 days later. If you miss the second dose, ask
your doctor for advice.
• A doctor, nurse or pharmacist will observe you for at
least 15 minutes after being given COMIRNATY.
5. What should I know while being given
COMIRNATY?
Things you should know
• If you receive one dose of COMIRNATY, you should
receive a second dose of the same vaccine at least 21
days later to complete the vaccination schedule.
• You may not be protected against COVID-19 disease
until at least seven days after your second dose.
• You may not be protected if you only receive one
dose, so a second dose Is Important.
Driving or using machines
Be careful before you drive or use any machines or tools
until you know how COMIRNATY affects you.
Some of the side effects of COMIRNATY may temporarily
affect your ability to drive or use machines.
Storage of the vaccine
COMIRNATY is stored at -90'C to -WC. It must be kept in
the original package In order to protect from light.
A doctor, nurse or pharmacist will prepare the Injection for
you before you are given It.
Getting rid of any unwanted vaccine
A doctor, nurse or pharmacist will dispose of any unused
vaccine.
6. Are there any side effects?
All medicines can have side effects. If you do experience
any side effects, most of them are minor an
However, some side effects may need medl
See the information below and, If you need to, ask your
doctor or pharmacist if you have any further questions
about side effects.
Very common side effects
Very common side effects What to do
• pain/swelling at Injection site
• tiredness
• headache
• muscle pain
• chills, fever
• Joint pain Speak to your
doctor If you
have any of
these very
common side
effects and
they worry you. Common side effects
Common side effects What to do
•
• redness at injection site
nausea Speak to your
doctor if you
have any of
these common
side effects and
they worry you.
Uncommon side effects
Uncommon side effects What to do
•
•
•
•
• enlarged lymph nodes
feeling unwell
pain In limb
insomnia
Itching at injection site Speak to your
doctor If you
have any of
these side
effects and
they worry you.
Rare side effects
Rare side effects What to do
• temporary one-sided facial
drooping Call your doctor
straight away,
or go straight
to the
Emergency
Department at
your nearest
hospital if you
notice this side
effect.
Other side effects (frequency unknown)
Other side effects (frequency
unknown) What to do
• severe allergic reaction Cali your doctor
straight away,
or go straight
to the
Emergency
Department at
your nearest
hospital if you
notice this
serious side
effect.
Tell your doctor or pharmacist if you notice anything else
that may be making you feel unwell.
Other side effects not listed here may occur in some
people.
Reporting side effects
After you have received medical advice for any side effects
you experience, you can report side effects to the
Therapeutic Goods Administration online at
www.teamov.au/reoortine-oroblems. By reporting side
COMIRNATY"' 3
EFTA00263314
📷 Images in this document (8 detected; 6 largest described)
AI-generated factual descriptions of embedded images (llava:13b). These are searchable across the corpus.
[Image 1] The image shows a document with text, which appears to be a vaccine information sheet. The document is titled "COVID-19 Vaccine" and includes sections with headings such as "COVID-19 Vaccine," "COVID-19 Vaccine Information," and "COVID-19 Vaccine Information Sheet." The text is in English and includes bullet points with information about the vaccine, including its name, manufacturer, and the date
[Image 2] The image shows a document with text and a table. The document appears to be a form or questionnaire with various sections and questions. The text is too small to read clearly, but there are headings and bullet points indicating different topics or questions. The table at the bottom of the page has columns with headings such as "Question," "Answer," and "Score," suggesting that it is used to rate
[Image 3] The image appears to be a photograph of a document, specifically a prescription. The document is written in English and contains various fields such as "Patient Name," "Prescriber," "Date," and "Dosage." There are also sections for "Drug Name," "Strength," "Quantity," and "Refills." The prescription is addressed to a patient and includes specific instructions for medication use. The text is clear
[Image 4] The image appears to be a document scan, specifically a letter or a report. The visible text includes the name "DR. DRAGANA LE" at the top, followed by a title "INSTRUCTOR" and a subtitle "INSTRUCTOR IN MEDICAL SCIENCES." Below this, there is a date "2015-05-25" and a location "UNIVERSITY OF MEDICINE AND PHARMACY." The visible text also includes a section titled "REPORT" with a subtitle "REPORT ON
[Image 5] The image shows a document that appears to be a letter or a report. The visible text includes the name "Dr. Richard Doube" and the name "Dr. Andrew Leung." The document is addressed to "Dr. Andrew Leung" and mentions "Kakadu Medical Associates." The visible text also includes a date "13 December 2012" and a reference number "12012." The document is partially obscured by a black rectangle, which su
[Image 6] The image shows a document that appears to be a letter or a form. The document is partially obscured, with the top right corner cut off, and the bottom left corner is also obscured. The visible text includes the name "JOSEPH CONRAD MEDICAL CENTER" and "MARINA MEDICAL CENTER," suggesting that the document is related to medical centers. There are also handwritten notes on the document, but the conte